Arcellx · 9 hours ago
Director, Investor Relations
Redwood City, CA
Full-time
Onsite
Director/Executive
$235K/yr - $265K/yr
8+ years expArcellx is a public, clinical-stage biotechnology company focused on innovative immunotherapies for cancer and other incurable diseases. The Director of Investor Relations will lead the investor relations program, collaborating with senior executives and managing communications with the financial community to support the company's mission.
BiopharmaBiotechnologyHealth CareLife SciencePharmaceutical
Responsibilities
Collaborates with the IRO on the development of the IR strategy, operating plan, and budget
Provides support for the following activities: Annual shareholder meeting, IR events at scientific meetings, Presentations at broker-sponsored conferences and meetings, Presentations at company-hosted conferences and meetings, Discussions with analysts and review of draft reports for accuracy of publicly disclosed information, Visits by the IRO and other senior leaders to institutional investors, Visits by investors to the company headquarters or other company sites
Manages the content for the IR website
Prepares data book or fact book/sheet – executes design, content, production, and delivery
Manages quarterly earnings process and deliverables, including script, deck, and Q&A materials
Assists with executing an impactful investor engagement program, including investor conferences, non-deal roadshows, IR days, annual meeting, on-site meetings, and other IR events
Delivers concise and impactful communications to support Arcellx’s participation at scientific conferences
Executes the collection, analysis, and presentation of feedback to the company of investors’ perceptions and opinions, brokerage security analysts’ positions and summaries, relative stock price movements, and periodic ownership analysis
Collaborates with Public Relations on developing key messages, integration, and consistency of messages and efforts
Conducts peer and competitive analysis of clinical pipelines and business models
Assists with delivering highly responsive and accurate communications to inbound inquiries from members of the financial community
Collects and manages analyst models
Collaborates on and assists with special projects as needed
Qualification
Required
Excellent attention to detail, with very strong verbal and interpersonal communication skills
Expert in excel and PowerPoint, with ability to understand and interpret financial statements and valuation models
Must be able to independently develop clear, concise and error-free word, PowerPoint and excel documents
Ability to work independently, lead meetings and work cross-functionally
A clear and thorough understanding of the financial modeling techniques used by security analysts to project a company's operating and financial performance and the resulting value for its stock
An energetic, efficient, and resourceful team player and individual contributor
Experience in the biotech or pharmaceutical industry and in analyzing and summarizing clinical data are essential
Preferred
BA degree in finance, life science or relevant field and minimum 10 years of relevant experience or an MBA and/or CFA with 8 years of related experience
Benefits
100% coverage for medical, dental and vision for team members and dependents
Unlimited vacation
A 3-day weekend every month
Fully-paid parental leave for up to 6 months
Tuition reimbursement
401k employer contribution
Relocation assistance for roles if required
Company
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
51-200 employees
H1B Sponsorship
Arcellx has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (4)
2022 (2)
Funding
Current Stage
Public CompanyTotal Funding
$622MKey Investors
Kite Pharma
2023-11-15Post Ipo Equity· $200M
2022-12-09Post Ipo Equity· $100M
2022-06-15Post Ipo Equity· $112M
Leadership Team
Michelle Gilson
Chief Financial Officer
Brad Gliner
Vice President, Clinical Research and Regulatory Affairs
Recent News
2025-12-11
2025-12-08
Company data provided by crunchbase